ZA200108116B - Drinkable pharmaceutical solution. - Google Patents

Drinkable pharmaceutical solution.

Info

Publication number
ZA200108116B
ZA200108116B ZA200108116A ZA200108116A ZA200108116B ZA 200108116 B ZA200108116 B ZA 200108116B ZA 200108116 A ZA200108116 A ZA 200108116A ZA 200108116 A ZA200108116 A ZA 200108116A ZA 200108116 B ZA200108116 B ZA 200108116B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical solution
drinkable pharmaceutical
drinkable
solution
pharmaceutical
Prior art date
Application number
ZA200108116A
Inventor
Christophe Lebon
Emmanuel Guerin
Pascal Suplie
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of ZA200108116B publication Critical patent/ZA200108116B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200108116A 1999-04-06 2001-10-03 Drinkable pharmaceutical solution. ZA200108116B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904251A FR2791888B1 (en) 1999-04-06 1999-04-06 ORAL PHARMACEUTICAL SUSPENSION

Publications (1)

Publication Number Publication Date
ZA200108116B true ZA200108116B (en) 2002-09-25

Family

ID=9544041

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200108116A ZA200108116B (en) 1999-04-06 2001-10-03 Drinkable pharmaceutical solution.
ZA200108206A ZA200108206B (en) 1999-04-06 2001-10-05 Oral pharmaceutical ibuprofen suspension.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200108206A ZA200108206B (en) 1999-04-06 2001-10-05 Oral pharmaceutical ibuprofen suspension.

Country Status (9)

Country Link
EP (1) EP1165043A1 (en)
CN (1) CN1351488A (en)
AU (1) AU778364B2 (en)
BR (1) BR0009551A (en)
FR (1) FR2791888B1 (en)
HU (1) HUP0200711A3 (en)
IL (1) IL145768A0 (en)
WO (1) WO2000059468A1 (en)
ZA (2) ZA200108116B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1411899T3 (en) * 2001-08-01 2009-06-02 Novartis Ag Taste-masking composition
US7300670B2 (en) * 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
KR20170052626A (en) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
DE3900811A1 (en) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh NEW MEDICINE
IE902829A1 (en) * 1989-08-14 1991-02-27 Eurand America Microencapsulated taste-masked water-insoluble nsaid drug¹materials
IL104093A (en) * 1991-12-31 1999-06-20 Abbott Lab Prolamine coatings for taste-masking orally administrable medicaments
EP0717992A3 (en) * 1994-12-21 1998-03-25 McNEIL-PPC, INC. Aqueous suspension formulations for pharmaceutical applications
EP0830135A1 (en) * 1995-05-09 1998-03-25 The Procter & Gamble Company Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders

Also Published As

Publication number Publication date
EP1165043A1 (en) 2002-01-02
ZA200108206B (en) 2002-12-24
AU3825200A (en) 2000-10-23
FR2791888A1 (en) 2000-10-13
HUP0200711A2 (en) 2002-07-29
BR0009551A (en) 2002-05-28
AU778364B2 (en) 2004-12-02
CN1351488A (en) 2002-05-29
HUP0200711A3 (en) 2003-04-28
WO2000059468A1 (en) 2000-10-12
FR2791888B1 (en) 2004-10-08
IL145768A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
HK1045650A1 (en) Pharmaceutical composition.
MXPA01013362A (en) ANTI-alphav.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
ZA200200477B (en) 2-pyrazolin-5-ones.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200202537B (en) Pour-on-formulations.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
ZA200101012B (en) Pharmaceutical combinations.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
HK1029502A1 (en) Slider-pull-assembling unit.
ZA200203707B (en) Pharmaceutical combinations.
ZA200000857B (en) Pharmaceutical composition.
ZA200110340B (en) Container.
ZA200203078B (en) Ciclesonide-containing aqueous pharmaceutical composition.
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
ZA200110454B (en) Pharmaceutical complex.
ZA200108481B (en) 8A- and 9A-15-membered lactams.
MXPA02000261A (en) Novel aminoindanes.
MXPA01011285A (en) Thio-oxindole derivatives.
ZA200108116B (en) Drinkable pharmaceutical solution.
HK1046133A1 (en) Pharmaceutical compounds.
ZA200204581B (en) Nitro-sulfobenzamides.
HK1031254A1 (en) Tachogragh.